Bp PLC Alnylam Pharmaceuticals, Inc. Transaction History

Bp PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$169.75 - $207.73 $495,839 - $606,779	-2,921 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$128.63 - $176.89 $151,526 - $208,376	-1,178 Reduced 28.74%	2,921 $495,000
Q1 2021 May 13, 2021	SELL	$126.83 - $175.69 $176,293 - $244,209	-1,390 Reduced 25.32%	4,099 $579,000
Q4 2020 Feb 08, 2021	SELL	$122.97 - $147.0 $579,311 - $692,517	-4,711 Reduced 46.19%	5,489 $713,000
Q3 2020 Oct 30, 2020	SELL	$121.19 - $165.49 $96,952 - $132,392	-800 Reduced 7.27%	10,200 $1.48 Million
Q4 2019 Feb 07, 2020	BUY	$74.51 - $124.23 $819,610 - $1.37 Million	11,000 New	11,000 $1.27 Million
Q3 2018 Nov 02, 2018	SELL	$87.52 - $122.67 $1.05 Million - $1.47 Million	-12,000 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$88.31 - $107.8 $1.06 Million - $1.29 Million	12,000 New	12,000 $1.18 Million

642

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.